 Connection
Olga Taraschenko to Male
This is a "connection" page, showing publications Olga Taraschenko has written about Male.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.439 |
|
|
|
-
Snehal I, Pulluru Y, Schissel M, Matyi J, Garlinghouse M, Ghonim HT, Phatak V, Taraschenko O. Impact of ictal spread on preoperative memory and language functions and postoperative seizure outcomes in drug-resistant epilepsy. Epilepsy Behav. 2025 Oct; 171:110497.
Score: 0.033
-
Taraschenko O, Fox HS, Heliso P, Al-Saleem F, Dessain S, Kim WY, Samuelson MM, Dingledine R. Memory loss and aberrant neurogenesis in mice exposed to patient anti-N-methyl-d-aspartate receptor antibodies. Exp Neurol. 2024 Aug; 378:114838.
Score: 0.031
-
Taraschenko O, Fox HS, Eldridge E, Heliso P, Al-Saleem F, Dessain S, Casale G, Willcockson G, Anderson K, Wang W, Dingledine R. MyD88-mediated signaling is critical for the generation of seizure responses and cognitive impairment in a model of anti-N-methyl-D-aspartate receptor encephalitis. Epilepsia. 2024 May; 65(5):1475-1487.
Score: 0.030
-
Malgireddy K, Gupta N, Baang HY, Samson KK, Madhavan D, Puccioni M, Taraschenko O. Risk of seizure clusters and status epilepticus following rapid and ultra-rapid medication discontinuation during intracranial EEG monitoring. Epilepsy Res. 2021 11; 177:106756.
Score: 0.025
-
Wei D, Zhou DJ, Datta P, Taraschenko O. Recognizing encephalopathy in immune checkpoint inhibitor therapy: A single-center experience. Cancer Med. 2021 05; 10(9):2978-2986.
Score: 0.025
-
Taraschenko O, Fox HS, Zekeridou A, Pittock SJ, Eldridge E, Farukhuddin F, Al-Saleem F, Devi Kattala C, Dessain SK, Casale G, Willcockson G, Dingledine R. Seizures and memory impairment induced by patient-derived anti-N-methyl-D-aspartate receptor antibodies in mice are attenuated by anakinra, an interleukin-1 receptor antagonist. Epilepsia. 2021 03; 62(3):671-682.
Score: 0.024
-
Datta P, Barrett W, Bentzinger M, Jasinski T, Jayagopal LA, Mahoney A, Pearon C, Swaminathan A, Vuppala A, Samson KK, Wang H, Taraschenko O. Ambulatory care for epilepsy via telemedicine during the COVID-19 pandemic. Epilepsy Behav. 2021 03; 116:107740.
Score: 0.024
-
Wei D, Garlinghouse M, Li W, Swingle N, Samson KK, Taraschenko O. Association between kinetic semiology of psychogenic nonepileptic spells and seizure type in dual disorder. Epilepsy Behav. 2021 01; 114(Pt A):107597.
Score: 0.024
-
Baang HY, Swingle N, Sajja K, Madhavan D, Shostrom VK, Taraschenko O. Towards Successes in the Management of Nonconvulsive Status Epilepticus: Tracing the Detection-to-Needle Trajectories. J Clin Neurophysiol. 2020 May; 37(3):253-258.
Score: 0.023
-
Taraschenko O, Fox HS, Pittock SJ, Zekeridou A, Gafurova M, Eldridge E, Liu J, Dravid SM, Dingledine R. A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis. Epilepsia. 2019 03; 60(3):452-463.
Score: 0.021
-
Wei D, Garlinghouse M, Li W, Swingle N, Samson KK, Taraschenko O. Utilization of brain imaging in evaluating patients with psychogenic nonepileptic spells. Epilepsy Behav. 2018 08; 85:177-182.
Score: 0.020
-
Arcot Jayagopal L, Samson KK, Taraschenko O. Driving with drug-resistant and controlled seizures from a patient's perspective: Assessment of attitudes and practices. Epilepsy Behav. 2018 04; 81:101-106.
Score: 0.020
-
Taraschenko OD, Amory CF, Waldman J, Hanspal EK, Bernardini GL. Lateral medullary stroke in patient with granulomatous polyangiitis. J Stroke Cerebrovasc Dis. 2014 May-Jun; 23(5):1259-61.
Score: 0.015
-
Taraschenko OD, Maisonneuve IM, Glick SD. Sex differences in high fat-induced obesity in rats: Effects of 18-methoxycoronaridine. Physiol Behav. 2011 Jun 01; 103(3-4):308-14.
Score: 0.012
-
Taraschenko OD, Maisonneuve IM, Glick SD. Resistance of male Sprague-Dawley rats to sucrose-induced obesity: effects of 18-methoxycoronaridine. Physiol Behav. 2011 Feb 01; 102(2):126-31.
Score: 0.012
-
Meletti S, Hanin A, Giovannini G, Bedin R, Burani M, Taruffi L, Orlandi N, Urbano T, D'Achille F, Malerba M, Basha MM, Eschbach K, Foreman B, Farias-Moeller R, Gaspard N, Gerard EE, Gofton T, Gopaul MT, Haider HA, Hantus ST, Herman S, Kang P, Day GS, Kandula P, Steriade C, Struck AF, Taraschenko O, Wainwright M, Yoo JY, Zhou DJ, Lattanzi S, Navarro V, Hirsch LJ. Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus. JAMA Neurol. 2026 Jun 01; 83(6):563-572.
Score: 0.009
-
Eliashiv D, Rao VR, Jobst BC, Szaflarski JP, Rolston JD, Kaye LC, Ganguly TM, Bullinger K, Dugan PC, Burdette DE, Peters AY, Sheikh A, Haas KF, Nair DR, Mnatsakanyan L, Quraishi IH, Bensalem-Owen MK, Doherty MJ, Razavi B, Fisher TL, Skidmore C, Modur PN, Constantino TM, Salanova V, Cole AJ, Taraschenko O, Rivera-Cruz A, Wheless JW, Tandon N, Balabanov A, Aboumatar S, Fried I, Drees C, Shin HW, Jaisani Z, MacIver SE, Patra SE, Chang EF, Willie JT, Gwinn R, Stoub T, Stern JM, Crabtree T, Seale CG, McFadden SC, Norman JF, Johnson L, Morrell MJ. Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results. Neurology. 2026 May 12; 106(9):e214875.
Score: 0.009
-
Bergdolt L, Anding A, Alshaqi O, Arbabi Z, Douchey M, Eldridge E, Hoffman K, Reid A, Sapkota K, Monaghan D, Taraschenko O, Padmashri R, Dunaevsky A. Contribution of astrocytic calcium signaling to auditory hypersensitivity in a mouse model of fragile X syndrome. Neurobiol Dis. 2026 May; 222:107355.
Score: 0.009
-
Hanin A, Marois C, Guillemaud M, Chavez M, Cosme L, Hayatou Z, Besnard A, Goudard G, Masson V, Cousyn L, Cheval M, Denis JA, Alkouri R, Lamari F, Bisulli F, Eschbach K, Farias-Moeller R, Gaspard N, Gerard EE, Giovannini G, Gofton T, Gopaul MT, Kellogg M, Meletti S, Muccioli L, Pasini E, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Wong N, Bonnefont-Rousselot D, Demeret S, Hirsch LJ, Navarro V. Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticus. Epilepsia. 2026 May; 67(5):2326-2346.
Score: 0.009
-
Gruen MD, Gopaul MT, Jimenez AD, Batra A, Blank LJ, Damien C, Day GS, Eschbach K, Gerard EE, Gofton TE, Hantus ST, Jette N, Jongeling A, Kang P, Kazazian K, Kellogg M, Kim M, Madani B, Morales M, Punia V, Steriade C, Struck A, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Gaspard N, Wong N, Hirsch LJ, Hanin A. Quality of life over time after new onset refractory status epilepticus. Epilepsia. 2026 01; 67(1):328-340.
Score: 0.008
-
Menousek J, Mordeson J, Dennis E, White ML, Taraschenko O, Abosch A. Enhanced Detection of Epileptogenic Zone Using Prisma 3T MRI in Patients with MRI-negative Focal Epilepsy. World Neurosurg. 2025 07; 199:124102.
Score: 0.008
-
Guillemaud M, Chavez M, Kobeissy F, Vezzani A, Jimenez AD, Basha MM, Batra A, Demeret S, Eka O, Eschbach K, Foreman B, Gaspard N, Gerard EE, Gofton TE, Haider HA, Hantus ST, Howe CL, Jongeling A, Kalkach-Aparicio M, Kandula P, Kazazian K, Kim M, Lai YC, Marois C, Mellor A, Mohamed W, Morales M, Pimentel CM, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Torcida Sedano N, Wainwright MS, Yoo JY, Wang KKW, Navarro V, Hirsch LJ, Hanin A. Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling. Neurol Neuroimmunol Neuroinflamm. 2025 Jul; 12(4):e200403.
Score: 0.008
-
Taraschenko OD, Barnes WG, Herrick-Davis K, Yokoyama Y, Boyd DL, Hough LB. Actions of tacrine and galanthamine on histamine-N-methyltransferase. Methods Find Exp Clin Pharmacol. 2005 Apr; 27(3):161-5.
Score: 0.008
-
Xue C, Kowshik SS, Lteif D, Puducheri S, Jasodanand VH, Zhou OT, Walia AS, Guney OB, Zhang JD, Poésy S, Kaliaev A, Andreu-Arasa VC, Dwyer BC, Farris CW, Hao H, Kedar S, Mian AZ, Murman DL, O'Shea SA, Paul AB, Rohatgi S, Saint-Hilaire MH, Sartor EA, Setty BN, Small JE, Swaminathan A, Taraschenko O, Yuan J, Zhou Y, Zhu S, Karjadi C, Alvin Ang TF, Bargal SA, Plummer BA, Poston KL, Ahangaran M, Au R, Kolachalama VB. AI-based differential diagnosis of dementia etiologies on multimodal data. Nat Med. 2024 Oct; 30(10):2977-2989.
Score: 0.008
-
Hanin A, Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel CM, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Wainwright MS, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ. Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis. Epilepsia. 2024 Aug; 65(8):e148-e155.
Score: 0.008
-
Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel C, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ, Hanin A. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis. Epilepsia. 2024 Jun; 65(6):e87-e96.
Score: 0.008
-
Karakis I, Lynam C, Taraschenko O, Staikova E, Drane DL. Concurrent EEG monitoring helps interpret neuropsychological testing results in patients with epilepsy. Epilepsy Behav. 2020 10; 111:107275.
Score: 0.006
-
Nalwalk JW, Svokos K, Taraschenko O, Leurs R, Timmerman H, Hough LB. Activation of brain stem nuclei by improgan, a non-opioid analgesic. Brain Res. 2004 Sep 24; 1021(2):248-55.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|